Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RANGRF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
IPMK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
TMEM259 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC01004 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
MIR637 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOX4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC39A8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
EIF5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
OGFR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GLYR1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TSC22D1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDH3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRA2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HEATR5B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MARK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MPRIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TADA2A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on